Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 26;11(5):819. doi: 10.3390/cells11050819

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Comparative efficacy of tezepelumab and dupilumab in terms of the change in pre-BD FEV_1.0 in patients with inadequately controlled asthma in overall participants and subgroups based on PBEC thresholds. Comparisons are expressed as tezepelumab versus dupilumab. Data are expressed as mean differences (MDs) and 95% credible intervals (CrIs). pre-BD FEV_1.0, pre-bronchodilator forced expiratory volume in one second; Teze, tezepelumab; Dupi, dupilumab; PBEC, peripheral blood eosinophil counts.